Login

Fulvio Citaredo, CEO di Pierrel Spa 00:00:00

Share On Facebook Share On Twitter

di Pierrel Spa

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Our goal is to treat cancer as well as inflammatory and autoimmune diseases|Göran Forsberg,CEO,Cantargia
00:10:00
Minerals "in a prime position" to supply the demand for spodumene | Nigel Broomham, CEO, Battery Age Minerals (IE)
00:00:00
Mike Timoney, Chief Executive Officer for Smiles Inclusive (SIL)
00:10:00
Understanding the 28% and 36% Rules for Home Buying | Ben Smith, Founder, Cove Financial Planning, LLC.
00:10:00
From 2 Million Deliveries to IPO: Steve Orenstein on Zoom2u's Journey | Steve Orenstein , CEO , Zoom2u Technologies Ltd.
00:10:00
Revolutionizing Lithium Recycling for a Sustainable Future | Ajay Kochhar, CEO, Li-Cycle Holdings Corp.
00:10:00
Improving health and well-being in our community|Robert G. Riney,President and CEO,Henry Ford Hospital
00:10:00
Discover the captivating tale of Fortitudo Ltd's latest property venture near Sandbanks Beach| Richard Carr,CEO,Fortitudo Ltd
00:10:00
Regulus Resources Showcases Advancements in Peru Copper Project at One-to-One Mining Conference
00:10:00
Seth Ravin, president and CEO of Rimini Street Inc., discusses his role and the company's software support services.
00:10:00
John Wood, CEO of Telos, discusses the origins and benefits of the partnership with AWS Public Sector.|John Wood, CEO of Telos Corporation
00:10:00
Catalent Acquires Paragon Bioservices: Expanding Capabilities in Gene Therapy

© 2026 Nehu